These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28315254)

  • 41. In Vitro Engulfment Assay to Measure Phagocytic Activity of Astrocytes Using Synaptosomes.
    Byun YG; Chung WS
    Methods Mol Biol; 2019; 1938():155-168. PubMed ID: 30617979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
    Jang JW; Song Y; Kim KM; Kim JS; Choi EK; Kim J; Seo H
    BMC Cancer; 2016 Oct; 16(1):810. PubMed ID: 27756242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pivotal role of multimodality reporter sensors in drug discovery: from cell based assays to real time molecular imaging.
    Ray P
    Curr Pharm Biotechnol; 2011 Apr; 12(4):539-46. PubMed ID: 21342103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products.
    Piccard H; Hu J; Fiten P; Proost P; Martens E; Van den Steen PE; Van Damme J; Opdenakker G
    Electrophoresis; 2009 Jul; 30(13):2366-77. PubMed ID: 19621364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.
    Sandercock AM; Rust S; Guillard S; Sachsenmeier KF; Holoweckyj N; Hay C; Flynn M; Huang Q; Yan K; Herpers B; Price LS; Soden J; Freeth J; Jermutus L; Hollingsworth R; Minter R
    Mol Cancer; 2015 Jul; 14():147. PubMed ID: 26227951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy.
    Vizovisek M; Ristanovic D; Menghini S; Christiansen MG; Schuerle S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single cell multiplexed assay for proteolytic activity using droplet microfluidics.
    Ng EX; Miller MA; Jing T; Chen CH
    Biosens Bioelectron; 2016 Jul; 81():408-414. PubMed ID: 26995287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-throughput screening of natural products for cancer therapy.
    Harvey AL; Cree IA
    Planta Med; 2010 Aug; 76(11):1080-6. PubMed ID: 20635309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Cell Painting Assay as a Screening Tool for the Discovery of Bioactivities in New Chemical Matter.
    Pahl A; Sievers S
    Methods Mol Biol; 2019; 1888():115-126. PubMed ID: 30519943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protease-Activated Sensors for In Vivo Imaging of Cell Populations.
    Eschliman K; Bossmann SH
    Methods Mol Biol; 2020; 2126():117-126. PubMed ID: 32112384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ellipsoid Segmentation Model for Analyzing Light-Attenuated 3D Confocal Image Stacks of Fluorescent Multi-Cellular Spheroids.
    Barbier M; Jaensch S; Cornelissen F; Vidic S; Gjerde K; de Hoogt R; Graeser R; Gustin E; Chong YT;
    PLoS One; 2016; 11(6):e0156942. PubMed ID: 27303813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
    McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
    Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a DsRed-expressing HepaRG cell line for real-time monitoring of hepatocyte-like cell differentiation by fluorescence imaging, with application in screening of novel geometric microstructured cell growth substrates.
    Uta M; Sima LE; Hoffmann P; Dinca V; Branza-Nichita N
    Biomed Microdevices; 2017 Mar; 19(1):3. PubMed ID: 28070697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of chronic and acute treatment effects on neuronal network activity using image and signal analysis: toward a high-content assay.
    Cornelissen F; Verstraelen P; Verbeke T; Pintelon I; Timmermans JP; Nuydens R; Meert T
    J Biomol Screen; 2013 Aug; 18(7):807-19. PubMed ID: 23606652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.
    Smirnova L; Harris G; Delp J; Valadares M; Pamies D; Hogberg HT; Waldmann T; Leist M; Hartung T
    Arch Toxicol; 2016 Nov; 90(11):2725-2743. PubMed ID: 26647301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease.
    Campos-Gomez J; Ahmad F; Rodriguez E; Saeed MF
    Virology; 2016 Sep; 496():77-89. PubMed ID: 27261892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A protease substrate profiling method that links site-specific proteolysis with antibiotic resistance.
    Sandersjöö L; Kostallas G; Löfblom J; Samuelson P
    Biotechnol J; 2014 Jan; 9(1):155-62. PubMed ID: 24243818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Live cell imaging: an industrial perspective.
    McCann T
    Methods Mol Biol; 2010; 591():47-66. PubMed ID: 19957123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and implementation of multiplexed cell-based imaging assays.
    Howell BJ; Lee S; Sepp-Lorenzino L
    Methods Enzymol; 2006; 414():284-300. PubMed ID: 17110198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activatable Zymography Probes Enable
    Soleimany AP; Kirkpatrick JD; Su S; Dudani JS; Zhong Q; Bekdemir A; Bhatia SN
    Cancer Res; 2021 Jan; 81(1):213-224. PubMed ID: 33106334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.